MediMix had the privilege of consulting with two experts, Prof Duhoux from...
Dr. Elisa Agostinetto, medical oncologist at the Institute Jules Bordet in...
Trastuzumab deruxtecan (T-DXd) has been approved for the treatment of...
Prof. François Duhoux from Cliniques Universitaires St Luc in Brussels shares...
The NeoRhea study is a phase 2 clinical trial that focuses on patients with...
Genomic signatures have shown promise in predicting the pathological complete...
The standard treatment for hormone receptor-positive HER2-negative advanced...
The benefit of immunotherapy in patients with metastatic breast cancer is...
Dr. Laure-Anne Teuwen, medical oncologist at the university hospital of Antwerp...
Today marks the start of the ASCO 2023 congress, with the first oral abstract...